Gerry Gleeson Email & Phone Number

Gerry Gleeson is a distinguished industry leader renowned for his expertise in large and small-molecule therapeutics, specialty drugs, biologics, and vaccines across diverse market access and trade landscapes. Possessing a keen focus on fostering highly efficient teams and nurturing next-generation leaders, Gerry has consistently driven organizational growth through decisive action-oriented strategies.Gerry’s extensive background encompasses comprehensive knowledge of US pricing and policy dynamics, particularly in areas related to the Inflation Reduction Act. A seasoned senior agile enterprise executive, Gerry has held pivotal P&L accountable roles, orchestrating successful negotiations with payers, wholesalers, and national account management teams to optimize Gross-to-Net (GTN) impact.Gerry's multifaceted career spans critical domains, including pricing strategy, government compliance and pricing, national account management, specialty pharmacy, and GTN management. He is adept at driving operational excellence in rebate administration and contract negotiations with payers, PBMs, and wholesalers. Moreover, Gerry excels in fostering innovation in new product development and market access strategies, while championing patient support services and integrated access data analytics for informed decision-making.In his most recent role as Head of US Market Access & Wholesale Trade at Sanofi, a global biopharmaceutical leader, Gerry showcased his prowess in building best-in-class market access and trade capabilities, positioning the company for sustained competitive advantage. Prior to Sanofi, he played a pivotal role at Walgreens, guiding the organization to become a major player in the US specialty pharmacy landscape.Gerry's leadership ethos revolves around trust, authenticity, and strategic agility. He is renowned for his ability to execute with precision while navigating dynamic market environments. With a proven track record of global executive leadership, Gerry remains committed to driving impactful outcomes and shaping the future of healthcare access and delivery.